
4 Studies Zoom In On Bexarotene for Alzheimer’s
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand

RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand

VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See

VIDEO See DBS turn a new, hopeful page in Alzheimer’s treatment. Learn how DBS (Deep Brain Stimulation) pacemakers send electrical signals deep into the brain,

Studies in mice with Alzheimer’s show that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth. Learn how this ability to protect learning and

Agitation can be a disruptive, chronic problem in Alzheimer’s. It increases caregiver burden as well as patient distress and is often the trigger to long-term

DEMENTIA GIFT IDEAS: People with Alzheimer’s may lose abilities, but feelings still matter. What once wasn’t much of a gift, may now be a great one. What were nice presents may no longer be right. See these thoughtful suggestions.

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Israel pairs the developed world’s highest birth rate with the lowest crude dementia prevalence in a major European comparison—an advantage rooted in demographics that gives the country valuable time to prepare better for caregivers and families.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


